Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

GlaxoSmithKline Q1 Net Profit Down, Core EPS Up - Quick Facts

RELATED NEWS
Trade GSK now with 

GlaxoSmithKline plc (GSK.L,GSK: Quote) reported a drop in first-quarter profit attributable to shareholders to 1.325 billion pounds from 1.525 billion pounds last year, with earnings per share falling to 26.3 pence from 29.6 pence a year ago.

However, core earnings per share for the recent quarter were 27.3 pence, higher than the prior-year quarter's 25.9 pence, up 7% in CER terms and 5% in sterling terms reflecting the strengthening of Sterling against the Euro and higher exchange losses on settled inter-company transactions, partly offset by the weakness of Sterling against the US Dollar and Japanese Yen.

Group turnover for the quarter went up 2% to 6.64 billion pounds from 6.585 billion pounds in the comparable period. In addition, the board has declared a first interim dividend of 17 pence per share. The company's 2012 outlook for sales growth and gradual expansion of core margin remained unchanged.

Click here to receive FREE breaking news email alerts for GlaxoSmithKline PLC and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
This apparel maker has doubled its earnings per share in just two years and regularly increasing its annual earnings forecast, despite a challenging consumer spending environment. Contributions from acquisitions, efficiency gains from self-owned global supply chain and benefits from 'Innovate-to-Elevate' strategy continue to boost the company's top-line and bottom-line results. Here is a quick summary of the earnings reported after the bell on Nov 20. We have 20+ stocks listed here. The good news is you can skip this step. There is a next move that can make your life a lot easier. Our research team has already done the groundwork for you. All these stocks listed... Design software maker Autodesk, Inc. said Thursday after the markets closed that its third quarter profit fell 81% from last year, as higher costs and expenses more than offset an 11% increase in revenue. However, the company's quarterly earnings per share, excluding items, came in above analysts' expectations as did its quarterly revenue.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.